$281 Million is the total value of WELCH CAPITAL PARTNERS LLC/NY's 40 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 50.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VOO | Buy | Vanguard S&P 500 ETF | $37,912,000 | +190.5% | 154,558 | +173.3% | 13.50% | +207.1% |
| XLB | Buy | Materials Select Sector SPDR Fundsbi materials | $9,690,000 | +26.3% | 160,090 | +18.5% | 3.45% | +33.5% |
| XLE | Buy | Energy Select Sector SPDR Fundenergy | $8,207,000 | +56.1% | 113,570 | +48.0% | 2.92% | +65.0% |
| IWM | Buy | iShares Russell 2000 ETFrussell 2000 etf | $7,245,000 | +83.7% | 47,518 | +78.5% | 2.58% | +94.2% |
| EVHC | Buy | Envision Healthcare Corp | $7,233,000 | -12.5% | 209,279 | +13.8% | 2.58% | -7.5% |
| WFC | New | Wells Fargo | $3,242,000 | – | 53,430 | +100.0% | 1.16% | – |
| KRE | New | SPDR S&P Regional Banking ETFs&p regl bkg | $2,908,000 | – | 49,410 | +100.0% | 1.04% | – |
| RRC | Buy | Range Resources Corp | $2,033,000 | +81.0% | 119,160 | +107.6% | 0.72% | +91.5% |
| BOX | New | Box Inc - Class Acl a | $226,000 | – | 10,712 | +100.0% | 0.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPIDERS INDEX | 42 | Q3 2023 | 52.7% |
| Alphabet Inc-Cl C | 32 | Q3 2023 | 6.3% |
| BLACKSTONE GROUP INC | 32 | Q3 2023 | 4.4% |
| HUMANA INC | 29 | Q3 2023 | 5.9% |
| CVS HEALTH CORP | 28 | Q4 2022 | 5.0% |
| Paypal Inc | 27 | Q3 2023 | 4.4% |
| BRIGHT HORIZONS FAMILY SOLUTIONS INC | 26 | Q3 2019 | 4.5% |
| Proctor & Gamble | 26 | Q3 2019 | 0.9% |
| UNITED TECHNOLOGIES | 26 | Q3 2019 | 0.2% |
| VANGUARD WORLD FDS | 25 | Q3 2023 | 41.4% |
View WELCH CAPITAL PARTNERS LLC/NY's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| HEALTHTRONICS SURGICAL SERVICES INC | February 12, 2004 | 9 | 11.0% |
| HMS HOLDINGS CORP | February 12, 2004 | 9 | 11.0% |
| REGENERATION TECHNOLOGIES INC | February 12, 2004 | 9 | 11.0% |
| SONUS PHARMACEUTICALS INC | February 12, 2004 | 9 | 11.0% |
| DRAXIS HEALTH INC /CN/ | March 07, 2003 | 9 | 11.0% |
| PRAECIS PHARMACEUTICALS INC | March 04, 2003 | 9 | 11.0% |
View WELCH CAPITAL PARTNERS LLC/NY's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-13 |
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-02 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-17 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-08 |
View WELCH CAPITAL PARTNERS LLC/NY's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.